Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 4 completed trials

    Completion Rate
    100%(4/4)
    Active Trials
    0(0%)
    Results Posted
    0%(0 trials)

    Phase Distribution

    Phase 4
    4
    100%

    Phase Distribution

    0

    Early Stage

    0

    Mid Stage

    4

    Late Stage

    Phase Distribution4 total trials
    Phase 4Post-market surveillance
    4(100.0%)

    Highest Phase Reached

    Phase 4

    Trial Status & Enrollment

    Completion Rate

    100.0%

    4 of 4 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    4

    all time

    Status Distribution
    Completed(4)

    Detailed Status

    Completed4

    Development Timeline

    Analytics

    Development Status

    Total Trials
    4
    Active
    0
    Success Rate
    100.0%
    Most Advanced
    Phase 4

    Trials by Phase

    Phase 44 (100.0%)

    Trials by Status

    completed4100%

    Recent Activity

    0 active trials
    Showing 4 of 4
    completedphase_4

    Evaluation of the Vi Polysaccharide Vaccine Against Typhoid Fever

    NCT00125008
    completedphase_4

    Combined Vi Vaccination and Health Education Program on the Burden of Typhoid in Childhood

    NCT00125047
    completedphase_4

    Introduction of the Vi Polysaccharide Typhoid Vaccine in Hue City, Central Vietnam

    NCT00131820
    completedphase_4

    Typhoid Vi Vaccine Effectiveness in Hechi, Guangxi, China

    NCT00131833

    Clinical Trials (4)

    Showing 4 of 4 trials
    NCT00125008Phase 4

    Evaluation of the Vi Polysaccharide Vaccine Against Typhoid Fever

    Completed
    NCT00125047Phase 4

    Combined Vi Vaccination and Health Education Program on the Burden of Typhoid in Childhood

    Completed
    NCT00131820Phase 4

    Introduction of the Vi Polysaccharide Typhoid Vaccine in Hue City, Central Vietnam

    Completed
    NCT00131833Phase 4

    Typhoid Vi Vaccine Effectiveness in Hechi, Guangxi, China

    Completed

    All 4 trials loaded

    Drug Details

    Intervention Type
    Biological
    Total Trials
    4